← Eichor
Study identifier: NCT07186413 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g Cream in Chinese Subjects With Acne Vulgaris

Condition: Acne Vulgaris  ·  Sponsor: Galderma R&D

PhasePhase 3
Planned participants561
Who can joinAll sexes, 9 Years to no upper limit
Healthy volunteersNo

About this study

The primary objective is to assess the efficacy of trifarotene 50 microgram per gram (mcg/g) cream versus vehicle cream when applied once daily (QD) for 12 weeks in Chinese participants with moderate facial and truncal acne vulgaris.

This description comes directly from the study's public registry record.

Talk to the study team

Galderma Research & Development  ·  817-961-5000  ·  Clinical.Studies@galderma.com

Always discuss trial participation with your own doctor first.

Locations (1)

Galderma Research & Development Site #5378Shanghai, Jing'an District, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07186413